The Legal Action Center is touting an initiative by the federal Department of Justice (DOJ) that is seeking to remove discriminatory barriers to medication‐assisted treatment (MAT) with methadone or buprenorphine for opioid use disorders. The DOJ's Civil Rights Division is working with U.S. attorney's offices around the country to educate stakeholders about how the Americans with Disabilities Act (ADA) protects people with substance use disorders, according to a December 2017 announcement by Acting Assistant Attorney General John Gore.The December announcement follows a letter from the U.S. attorney in the Southern District to the New York State Office of the Attorney General explaining that under the ADA, courts may not prohibit the use of MAT. In the letter, clear examples of illegal discrimination are described, such as: “… a court generally could not deny a parent visitation of her child by reason of the parent's … current use of MAT. Nor could a court impose a blanket rule requiring parents to stop participating in MAT in order to gain custody of their children.”“The DOJ has never sent a letter like this before,” said Sally Friedman, legal director with the Legal Action Center. “It was a first‐time‐ever event.”The DOJ letter was
Alcoholism and Drug Abuse Weekly – Wiley
Published: Jan 12, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera